Syed Ali, PharmD

Head Of Medical Field Teams & MA Operations at Taiho Oncology, Inc.

Syed Ali, PharmD, has extensive work experience in the pharmaceutical industry. Syed began their career at Walgreens in 2004, where they served as a Pharmacy Manager, overseeing a high-volume 24-hour pharmacy. Syed was also involved in district-wide projects and collaborated with Well-Care Insurance Team for promotional initiatives. In 2016, Syed transitioned to the role of Area Healthcare Supervisor at Walgreens Boots Alliance, where they were responsible for enhancing pharmacy operations and providing exceptional customer care. Syed also served as the Manager of Retail Operations, supervising staff and improving pharmacy sales. In 2019, Syed joined Medicos Specialty Solutions as a Senior MSL, a role they held until 2020. Syed then joined Pfizer as the Director of Field Medical for Immuno-Inflammation, a position that they held until 2022. Syed's most recent role is with Taiho Oncology, Inc. as the Senior Director of the National Medical Field Team, where they are responsible for translating medical team strategies, developing and executing medical field components in product launch plans, and driving process improvements within the organization.

Syed Ali, PharmD has a Doctor of Pharmacy degree (PharmD) from the Federal Urdu University of Arts, Science & Technology, Islamabad. Syed also has a PharmB degree from Karachi University. Additionally, they have obtained certifications in HIV Pharmacotherapy from the University at Buffalo in October 2012, Immunization from the NY state board of Pharmacy in August 2012, and Applied Drug Store Management from Walgreens in August 2008.

Location

Princeton, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Taiho Oncology, Inc.

2 followers

The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com


Employees

201-500

Links